 |
인쇄하기
취소
|
Hyundai to release anti-oxidant therapy in 2014
Hyundai Pharm has recently entered into a licensing agreement with Nippon Zoki Pharmaceutical Co. to develop and commercialize a new anti-oxidant (code name: HD003) for treatment of chronic renal failure (CRF).
According to Hyudai officials, HD003 in a tablet form may be available on the market in 2014 after completion of clinical trials here.
HD003 is expected to delay or possibly arrest...
According to Hyudai officials, HD003 in a tablet form may be available on the market in 2014 after completion of clinical trials here.
HD003 is expected to delay or possibly arrest...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.